PublicationInternational Journal of Radiation Oncology, Biology, Physics
November 1, 2021
Contributed by:
Tringale, K.R., Casey, D.L., Niyazov, G., Wolden, S.L.
A follow-up study published in the International Journal of Radiation Oncology, Biology, Physics on Nov. 1, 2021, demonstrated that childhood cancer survivors, who received intensity-modulated radiation therapy, had an increased risk of developing second malignant neoplasms (SMNs). The study findings suggest that alternatives to IMRT, including proton beam therapy (PBT) should be considered. As an alternative modality for radiation treatment, proton therapy delivers radiation to a tumor in a precisely planned dose, thereby minimizing potential damage to surrounding normal tissue and reducing the cumulative incidence of malignant recurrence.
